Dalhoff K, Braun J, Hollandt H, Lipp R, Wiessmann K J, Marre R
Klinik für Innere Medizin, Medizinischen Universität Lübeck, Germany.
Infection. 1993 Sep-Oct;21(5):291-6. doi: 10.1007/BF01712447.
In 29 patients with community-acquired pneumonia, 24 patients with hospital-acquired pneumonia and 35 patients with pneumonia in the immunocompromised host the diagnostic value of bronchoalveolar lavage (BAL) with quantitative bacterial and fungal cultures was studied; 32 patients with noninfectious pulmonary diseases and 14 healthy volunteers served as controls. An infectious etiology could be established in 81% of the pneumonia patients without differences between the three groups; significant infection was associated with colony counts of > or = 10(4) cfu/ml. Prior antibiotic therapy lowered the yield of BAL culture only in community-acquired pneumonia (94% vs 55% positive cultures in untreated vs pretreated patients, p < 0.02). Furthermore the culture results were related to the radiographic extension of pulmonary infiltrates (92% positive cultures in multilobar vs 54% in lobar or segmental infiltrates, p < 0.001). Therapeutic consequences of BAL were shown by resistance of the isolated organisms to predefined empiric treatment regimens in 41% community-acquired pneumonia, 43% pneumonia in the immunocompromised host and 67% hospital-acquired pneumonia patients.
对29例社区获得性肺炎患者、24例医院获得性肺炎患者和35例免疫功能低下宿主肺炎患者进行了支气管肺泡灌洗(BAL)定量细菌和真菌培养的诊断价值研究;32例非感染性肺部疾病患者和14名健康志愿者作为对照。81%的肺炎患者可确定感染病因,三组之间无差异;显著感染与菌落计数≥10⁴cfu/ml相关。既往抗生素治疗仅降低了社区获得性肺炎患者BAL培养的阳性率(未治疗患者与预处理患者的阳性培养率分别为94%和55%,p<0.02)。此外,培养结果与肺部浸润的影像学范围相关(多叶浸润患者的阳性培养率为92%,叶或段浸润患者为54%,p<0.001)。41%的社区获得性肺炎患者、43%的免疫功能低下宿主肺炎患者和67%的医院获得性肺炎患者中,分离出的病原体对预定义的经验性治疗方案耐药,显示了BAL的治疗效果。